Amicus Therapeutics (Call) (FOLD) Stake Has Raised by Tourbillon Capital Partners Lp; Texas Permanent School Fund Increases Holding in Third Pt Reins LTD (TPRE)

April 17, 2018 - By Vivian Currie

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Logo

Texas Permanent School Fund increased its stake in Third Pt Reins Ltd (TPRE) by 107.05% based on its latest 2017Q4 regulatory filing with the SEC. Texas Permanent School Fund bought 30,399 shares as the company’s stock declined 7.89% with the market. The institutional investor held 58,796 shares of the property-casualty insurers company at the end of 2017Q4, valued at $861,000, up from 28,397 at the end of the previous reported quarter. Texas Permanent School Fund who had been investing in Third Pt Reins Ltd for a number of months, seems to be bullish on the $1.36B market cap company. The stock increased 0.56% or $0.07 during the last trading session, reaching $13.38. About 13,646 shares traded. Third Point Reinsurance Ltd. (NYSE:TPRE) has risen 19.15% since April 17, 2017 and is uptrending. It has outperformed by 7.60% the S&P500.

Jason Karp increased its stake in Amicus Therapeutics Inc (Call) (FOLD) by 180% based on its latest 2017Q4 regulatory filing with the SEC. Tourbillon Capital Partners Lp bought 450,000 shares as the company’s stock rose 0.85% while stock markets declined. The hedge fund run by Jason Karp held 700,000 shares of the health care company at the end of 2017Q4, valued at $10.07 million, up from 250,000 at the end of the previous reported quarter. Tourbillon Capital Partners Lp who had been investing in Amicus Therapeutics Inc (Call) for a number of months, seems to be bullish on the $2.75B market cap company. The stock increased 1.55% or $0.22 during the last trading session, reaching $14.61. About 142,480 shares traded. Amicus Therapeutics, Inc. (NASDAQ:FOLD) has risen 90.40% since April 17, 2017 and is uptrending. It has outperformed by 78.85% the S&P500.

Among 9 analysts covering Amicus Therapeutics (NASDAQ:FOLD), 8 have Buy rating, 0 Sell and 1 Hold. Therefore 89% are positive. Amicus Therapeutics had 22 analyst reports since August 18, 2015 according to SRatingsIntel. Chardan Capital Markets upgraded Amicus Therapeutics, Inc. (NASDAQ:FOLD) rating on Monday, October 5. Chardan Capital Markets has “Buy” rating and $8 target. The firm has “Buy” rating by Cowen & Co given on Sunday, June 25. The stock of Amicus Therapeutics, Inc. (NASDAQ:FOLD) earned “Neutral” rating by Chardan Capital Markets on Wednesday, September 16. The stock of Amicus Therapeutics, Inc. (NASDAQ:FOLD) earned “Buy” rating by Leerink Swann on Monday, August 31. The firm has “Neutral” rating given on Thursday, April 14 by Robert W. Baird. Robert W. Baird maintained Amicus Therapeutics, Inc. (NASDAQ:FOLD) on Wednesday, July 12 with “Outperform” rating. The rating was maintained by Leerink Swann on Monday, October 5 with “Outperform”. On Tuesday, August 18 the stock rating was downgraded by Zacks to “Buy”. Robert W. Baird upgraded the stock to “Outperform” rating in Tuesday, January 24 report. Robert W. Baird maintained Amicus Therapeutics, Inc. (NASDAQ:FOLD) rating on Wednesday, February 7. Robert W. Baird has “Buy” rating and $20.0 target.

Investors sentiment decreased to 1.21 in Q4 2017. Its down 1.12, from 2.33 in 2017Q3. It dived, as 25 investors sold FOLD shares while 48 reduced holdings. 25 funds opened positions while 63 raised stakes. 197.59 million shares or 2.54% more from 192.70 million shares in 2017Q3 were reported. Moreover, Tiaa Cref Mngmt Lc has 0.01% invested in Amicus Therapeutics, Inc. (NASDAQ:FOLD). Susquehanna Interest Limited Liability Partnership has invested 0% in Amicus Therapeutics, Inc. (NASDAQ:FOLD). 69,951 were accumulated by Legal General Group Incorporated Public Ltd Company. Dimensional Fund Advisors Lp invested 0% in Amicus Therapeutics, Inc. (NASDAQ:FOLD). Us Bankshares De holds 0% or 817 shares. Prelude Capital Mgmt Lc holds 48,848 shares. Axa reported 0.03% stake. Victory holds 0.08% of its portfolio in Amicus Therapeutics, Inc. (NASDAQ:FOLD) for 2.64 million shares. Parallax Volatility Advisers Lp stated it has 0% of its portfolio in Amicus Therapeutics, Inc. (NASDAQ:FOLD). State Board Of Administration Of Florida Retirement Sys holds 79,221 shares or 0% of its portfolio. Price T Rowe Associates Md holds 0.02% in Amicus Therapeutics, Inc. (NASDAQ:FOLD) or 9.06M shares. Royal Bancorporation Of Canada reported 471,009 shares. Td Asset Mngmt has 0% invested in Amicus Therapeutics, Inc. (NASDAQ:FOLD) for 217,754 shares. Dekabank Deutsche Girozentrale owns 70,900 shares. Zurcher Kantonalbank (Zurich Cantonalbank) has 9,716 shares.

Since October 17, 2017, it had 3 insider purchases, and 14 sales for $4.83 million activity. 10,000 Amicus Therapeutics, Inc. (NASDAQ:FOLD) shares with value of $147,181 were sold by Baird William D III. 100,000 shares valued at $1.39 million were bought by PERCEPTIVE ADVISORS LLC on Friday, March 2. Another trade for 20,000 shares valued at $336,000 was made by Barth Jay on Tuesday, January 23. The insider RAAB MICHAEL sold 9,366 shares worth $140,490. Another trade for 5,000 shares valued at $71,343 was sold by Andrews Kurt J.. HAYDEN DONALD J JR had sold 20,000 shares worth $300,002.

Tourbillon Capital Partners Lp, which manages about $1.12 billion and $2.70B US Long portfolio, decreased its stake in Discovery Communicatns New (NASDAQ:DISCA) by 3.05M shares to 834,179 shares, valued at $18.67M in 2017Q4, according to the filing. It also reduced its holding in Sarepta Therapeutics Inc (Call) (NASDAQ:SRPT) by 370,400 shares in the quarter, leaving it with 1.10 million shares, and cut its stake in Sarepta Therapeutics Inc (Put) (NASDAQ:SRPT).

Investors sentiment increased to 3.26 in 2017 Q4. Its up 1.02, from 2.24 in 2017Q3. It is positive, as 12 investors sold TPRE shares while 22 reduced holdings. 34 funds opened positions while 77 raised stakes. 151.48 million shares or 90.11% more from 79.68 million shares in 2017Q3 were reported. Alliancebernstein LP invested in 363,480 shares. Bnp Paribas Arbitrage Sa holds 41,107 shares. Bank & Trust Of New York Mellon has 1.14 million shares. Zurcher Kantonalbank (Zurich Cantonalbank) invested in 0% or 4,430 shares. Bank Of America De owns 1.58 million shares. California State Teachers Retirement System holds 0% of its portfolio in Third Point Reinsurance Ltd. (NYSE:TPRE) for 144,960 shares. Rhumbline Advisers owns 185,944 shares. Bridgeway Capital Mgmt Inc holds 82,300 shares or 0.01% of its portfolio. Dupont Capital Corporation accumulated 99,664 shares. Zebra Capital reported 0.24% of its portfolio in Third Point Reinsurance Ltd. (NYSE:TPRE). Matarin Cap Limited Liability Company stated it has 643,979 shares or 0.73% of all its holdings. Allen Inv Management Ltd has invested 0.08% in Third Point Reinsurance Ltd. (NYSE:TPRE). 3,699 were reported by Meeder Asset Management. Renaissance Techs Lc reported 0.01% stake. Texas Permanent School Fund holds 0.01% of its portfolio in Third Point Reinsurance Ltd. (NYSE:TPRE) for 58,796 shares.

Texas Permanent School Fund, which manages about $7.99 billion US Long portfolio, decreased its stake in Msci Inc (NYSE:MSCI) by 4,870 shares to 60,877 shares, valued at $7.70 million in 2017Q4, according to the filing. It also reduced its holding in Marketaxess Hldgs Inc (NASDAQ:MKTX) by 2,032 shares in the quarter, leaving it with 25,407 shares, and cut its stake in Steel Dynamics Inc (NASDAQ:STLD).

Among 6 analysts covering Third Point Reinsurance (NYSE:TPRE), 2 have Buy rating, 0 Sell and 4 Hold. Therefore 33% are positive. Third Point Reinsurance had 14 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Third Point Reinsurance Ltd. (NYSE:TPRE) has “Equal-Weight” rating given on Friday, November 10 by Morgan Stanley. The stock has “Hold” rating by Keefe Bruyette & Woods on Monday, October 16. Keefe Bruyette & Woods maintained the shares of TPRE in report on Friday, September 8 with “Buy” rating. The firm has “Buy” rating by Compass Point given on Wednesday, September 2. Keefe Bruyette & Woods upgraded Third Point Reinsurance Ltd. (NYSE:TPRE) on Monday, May 8 to “Outperform” rating. The stock of Third Point Reinsurance Ltd. (NYSE:TPRE) earned “Hold” rating by Keefe Bruyette & Woods on Monday, December 4. The company was maintained on Tuesday, April 3 by Bank of America. Wood maintained the stock with “Market Perform” rating in Thursday, October 1 report. The firm has “Buy” rating by Keefe Bruyette & Woods given on Tuesday, October 10. Keefe Bruyette & Woods maintained the shares of TPRE in report on Thursday, August 3 with “Buy” rating.

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Vivian Currie

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: